Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Progress in Lipid Research
|
October 26, 2010
Sphingolipids and expression regulation of genes in cancer
Gauri A Patwardhan, Yong-Yu Liu
Journal of Bioenergetics and Biomembranes
|
January 27, 2015
Sphingolipids and mitochondrial apoptosis
Gauri A Patwardhan, Levi J Beverly, Leah J Siskind
Cancer Research
|
February 1, 2011
Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells
Yong-Yu Liu, Gauri A Patwardhan, Kaustubh Bhinge, et al.
NPJ Breast Cancer
|
May 27, 2021
Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
Gauri A Patwardhan, Michal Marczyk, Vikram B Wali, et al.
International Journal of Molecular Sciences
|
June 13, 2025
Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance
Md Saqline Mostaq, Lin Kang, Gauri A Patwardhan, et al.
International Journal of Oncology
|
May 28, 2011
Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma
Yong-Yu Liu, Gauri A Patwardhan, Ping Xie, et al.
Biochimica Et Biophysica Acta
|
July 29, 2015
Ceramide channels: destabilization by Bcl-xL and role in apoptosis
Kai-Ti Chang, Andriy Anishkin, Gauri A Patwardhan, et al.
Journal of Lipid Research
|
October 15, 2009
Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase
Vineet Gupta, Gauri A Patwardhan, Qian-Jin Zhang, et al.
Biochimica Et Biophysica Acta
|
September 9, 2014
Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells
Gauri A Patwardhan, Salman B Hosain, David X Liu, et al.
Scientific Reports
|
October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
Vikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Progress in Lipid Research
|
October 26, 2010
Sphingolipids and expression regulation of genes in cancer
Gauri A Patwardhan, Yong-Yu Liu
Journal of Bioenergetics and Biomembranes
|
January 27, 2015
Sphingolipids and mitochondrial apoptosis
Gauri A Patwardhan, Levi J Beverly, Leah J Siskind
Cancer Research
|
February 1, 2011
Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells
Yong-Yu Liu, Gauri A Patwardhan, Kaustubh Bhinge, et al.
NPJ Breast Cancer
|
May 27, 2021
Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
Gauri A Patwardhan, Michal Marczyk, Vikram B Wali, et al.
International Journal of Molecular Sciences
|
June 13, 2025
Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance
Md Saqline Mostaq, Lin Kang, Gauri A Patwardhan, et al.
International Journal of Oncology
|
May 28, 2011
Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma
Yong-Yu Liu, Gauri A Patwardhan, Ping Xie, et al.
Biochimica Et Biophysica Acta
|
July 29, 2015
Ceramide channels: destabilization by Bcl-xL and role in apoptosis
Kai-Ti Chang, Andriy Anishkin, Gauri A Patwardhan, et al.
Journal of Lipid Research
|
October 15, 2009
Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase
Vineet Gupta, Gauri A Patwardhan, Qian-Jin Zhang, et al.
Biochimica Et Biophysica Acta
|
September 9, 2014
Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells
Gauri A Patwardhan, Salman B Hosain, David X Liu, et al.
Scientific Reports
|
October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
Vikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
Page
of 2